Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans.
Saved in:
| Title: | Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans. |
|---|---|
| Authors: | Patel K; d3 Medicine, A Certara Company, Parsippany, NJ, USA.; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia., Kirkpatrick CM; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia., Nieforth KA; d3 Medicine, A Certara Company, Parsippany, NJ, USA., Chanda S; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., Zhang Q; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., McClure M; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., Fry J; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., Symons JA; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., Blatt LM; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., Beigelman L; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA., DeVincenzo JP; Departments of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, and Children's Foundation Research Institute at LeBonheur Children's Hospital, Memphis, TN, USA., Huntjens DR; Janssen R&D, Janssen Pharmaceutica NV, Beerse, Belgium., Smith PF; d3 Medicine, A Certara Company, Parsippany, NJ, USA. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2019 Feb 01; Vol. 74 (2), pp. 442-452. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30376079 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; d3 Medicine, A Certara Company, Parsippany, NJ, USA.; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kirkpatrick+CM%22">Kirkpatrick CM</searchLink>; Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Nieforth+KA%22">Nieforth KA</searchLink>; d3 Medicine, A Certara Company, Parsippany, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Chanda+S%22">Chanda S</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22McClure+M%22">McClure M</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fry+J%22">Fry J</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Symons+JA%22">Symons JA</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Blatt+LM%22">Blatt LM</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Beigelman+L%22">Beigelman L</searchLink>; Alios BioPharma Inc, a Janssen Pharmaceutical Company of Johnson and Johnson, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22DeVincenzo+JP%22">DeVincenzo JP</searchLink>; Departments of Pediatrics and Microbiology, Immunology and Biochemistry, University of Tennessee Center for Health Sciences, and Children's Foundation Research Institute at LeBonheur Children's Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Huntjens+DR%22">Huntjens DR</searchLink>; Janssen R&D, Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Smith+PF%22">Smith PF</searchLink>; d3 Medicine, A Certara Company, Parsippany, NJ, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227513617%22">The Journal of antimicrobial chemotherapy</searchLink> [J Antimicrob Chemother] 2019 Feb 01; Vol. 74 (2), pp. 442-452. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7513617 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2091 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203057453%22">03057453 </searchLink><i>NLM ISO Abbreviation: </i>J Antimicrob Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30376079 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dky415 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 442 Titles: – TitleFull: Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Patel K – PersonEntity: Name: NameFull: Kirkpatrick CM – PersonEntity: Name: NameFull: Nieforth KA – PersonEntity: Name: NameFull: Chanda S – PersonEntity: Name: NameFull: Zhang Q – PersonEntity: Name: NameFull: McClure M – PersonEntity: Name: NameFull: Fry J – PersonEntity: Name: NameFull: Symons JA – PersonEntity: Name: NameFull: Blatt LM – PersonEntity: Name: NameFull: Beigelman L – PersonEntity: Name: NameFull: DeVincenzo JP – PersonEntity: Name: NameFull: Huntjens DR – PersonEntity: Name: NameFull: Smith PF IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2019 Feb 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1460-2091 Numbering: – Type: volume Value: 74 – Type: issue Value: 2 Titles: – TitleFull: The Journal of antimicrobial chemotherapy Type: main |
| ResultId | 1 |